相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
Michael A. Carducci et al.
CANCER (2007)
A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden
Celine Le Gall et al.
CANCER RESEARCH (2007)
Fusion of metabolic function and morphology:: Sequential [18F] fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer
Yong Du et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor ανβ3 integrin is a therapeutic target for breast cancer bone metastases
Yingshe Zhao et al.
CANCER RESEARCH (2007)
The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer
Jesco Pfitzenmaier et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: Comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography
Jin Hur et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2007)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis
Delphine Javelaud et al.
CANCER RESEARCH (2007)
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?
Simon A. Williams et al.
PROSTATE (2007)
Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation
Gregory A. Clines et al.
MOLECULAR ENDOCRINOLOGY (2007)
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo
Jeroen T. Buijs et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis
Taku Nakagawa et al.
CANCER RESEARCH (2006)
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Jianhua Wang et al.
CANCER AND METASTASIS REVIEWS (2006)
Molecular mechanisms of action of bisphosphonates: Current status
Anke J. Roelofs et al.
CLINICAL CANCER RESEARCH (2006)
Biology of bone cancer pain
Michael J. Goblirsch et al.
CLINICAL CANCER RESEARCH (2006)
The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells
Julie A. Sterling et al.
CANCER RESEARCH (2006)
Genes associated with breast cancer metastatic to bone
Marcel Smid et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Systematic review: Bisphosphonates and osteonecrosis of the jaws
Sook-Bin Woo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer
N Tsuchiya et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
T Powles et al.
BREAST CANCER RESEARCH (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
RE Coleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization
MA Sevcik et al.
PAIN (2005)
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
CC Lynch et al.
CANCER CELL (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Endothelin receptor antagonists
JB Nelson
WORLD JOURNAL OF UROLOGY (2005)
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
A Javed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
GA Clines et al.
ENDOCRINE-RELATED CANCER (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
A Boucharaba et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - A randomized, phase III, double-blind, placebo-controlled trial
LS Rosen et al.
CANCER (2004)
Endothelin and the tumorigenic component of bone cancer pain
CM Peters et al.
NEUROSCIENCE (2004)
Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients
SM Ranuncolo et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
JJ Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 trial)
DP Dearnaley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women:: survival analysis and updated safety results
JM Nabholtz et al.
EUROPEAN JOURNAL OF CANCER (2003)
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF UROLOGY (2003)
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women:: Analysis of survival and update of efficacy from the international letrozole breast cancer group
H Mouridsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan
JB Nelson et al.
JOURNAL OF UROLOGY (2003)
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial
MA Carducci et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival
L Nakopoulou et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
F Saad et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Diagnostic evaluation of low back pain with emphasis on imaging
JG Jarvik et al.
ANNALS OF INTERNAL MEDICINE (2002)
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
T Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status
L Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women
HM Heshmati et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro
T Yoneda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Integrin activation controls metastasis in human breast cancer
B Felding-Habermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
JA Cauley et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
A N-terminal PTHrP peptide fragment void of a PTH/PTHrP-receptor binding domain activates cardiac ETA receptors
KD Schluter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines
JL Sanders et al.
ENDOCRINOLOGY (2000)
Calcium stimulates parathyroid hormone-related protein production in Leydig tumor cells through a putative cation-sensing mechanism
N Buchs et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis
J Seidenfeld et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
